SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital AdmissionPeter S. Hamblin, Leon A. Bach, Elif I. Ekinci et al.|The Journal of Clinical Endocrinology & Metabolism|2019Cited by 122